Effects of aging on agmatine levels in memory-associated brain structures
✍ Scribed by Ping Liu; Sree Chary; Renuka Devaraj; Yu Jing; Cynthia L. Darlington; Paul F. Smith; Ian G. Tucker; Hu Zhang
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 123 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1050-9631
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Agmatine is a metabolite of L‐arginine by arginine decarboxylase. Recent evidence suggests that it exists in mammalian brain and is a novel neurotransmitter. The present study measured agmatine levels in several memory‐associated brain structures in aged (24‐month‐old), middle‐aged (12‐month‐old), and young (4‐month‐old) male Sprague Dawley rats using liquid chromatography/mass spectrometry. Agmatine levels were significantly decreased in the CA1, but increased in the CA2/3 and dentate gyrus, subregions of the hippocampus in aged and middle‐aged rats relative to the young adults. In the prefrontal cortex, a dramatic decrease in agmatine level was found in aged rats as compared with middle‐aged and young rats. There were significantly increased levels of agmatine in the entorhinal and perirhinal cortices in aged relative to middle‐aged and young rats. In the postrhinal and temporal cortices, agmatine levels were significantly increased in aged and middle‐aged rats as compared with young adults. The present findings, for the first time, demonstrate age‐related changes in agmatine levels in memory‐associated brain structures and raise a novel issue of the potential involvement of agmatine in the aging process. © 2008 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract Acute psychosocial stress in humans triggers the release of glucocorticoids (GCs) and influences performance in declarative and working memory (WM) tasks. These memory systems rely on the hippocampus and prefrontal cortex (PFC), where GC‐binding receptors are present. Previous studies r
The sources and fates of brain ethanolamine (Etn) are poorly known and the effects of its administration have not been investigated, even though cortical levels are known to be reduced in certain neurodegenerative diseases. We studied the effect of different Etn doses (10(-3), 5 x 10(-3) and 10(-2)
Cocaine-induced increases in extracellular dopamine (DA) concentrations were measured using in vivo microdialysis techniques in the nucleus accumbens (NACC) of freely moving rats. In control animals, cocaine increased extracellular DA concentrations approximately 482% 60 min following administration